• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virology . Differential outcomes of viral co-infections with high pathogenicity avian influenza A(H5N6) and SARS-CoV-2 in mammalian in vitro systems

tetano

Editor, Senior Moderator
Virology


. 2026 Apr 9:620:110912.
doi: 10.1016/j.virol.2026.110912. Online ahead of print.
Differential outcomes of viral co-infections with high pathogenicity avian influenza A(H5N6) and SARS-CoV-2 in mammalian in vitro systems

Samuel A S Richardson[SUP] 1 [/SUP], Nitish Boodhoo[SUP] 2 [/SUP], Sushant Bhat[SUP] 3 [/SUP], Joanna Wells[SUP] 4 [/SUP], Philippa C Hawes[SUP] 5 [/SUP], Holly Shelton[SUP] 4 [/SUP], Dagmara Bialy[SUP] 6 [/SUP]


Affiliations
Abstract

Co-infection with two highly pathogenic viruses is often expected to worsen disease severity. However, increasing evidence suggests that viral interactions can be antagonistic, with one virus suppressing the other. In this study, we used various mammalian in vitro models to investigate the outcomes of co-infections with two highly pathogenic viruses: recombinant avian influenza A(H5N6) (A/chicken/Jiangxi/02.05 YGYXG023-P/2015) and an early isolate of SARS-CoV-2 (England/2/2020). Despite the use of identical viral strains and standardized experimental conditions, co-infection outcomes varied substantially across the models. In interferon-deficient Vero cells, SARS-CoV-2 (CoV) strongly outcompeted recombinant high pathogenicity avian influenza A(H5N6) virus (IV), leading to near-complete suppression of IV replication. This effect was reversed when IV was given a head start prior to secondary infection with CoV. In Calu-3 lung epithelial cells, both viruses could replicate simultaneously, with limited interference, however IV showed a dominant effect during both sequential co-infections (pre-infection and secondary infection), significantly limiting CoV replication. In contrast, human nasal airway epithelial cells (hNAECs) cultured at the air-liquid interface (ALI) supported efficient co-replication of both viruses with minimal interference. Bioimaging of co-infected hNAECs revealed that both viruses were spatially segregated, with no evidence of co-infection within the same cells. These findings demonstrate that the IV/CoV interactions are highly context-dependent and can shift significantly even with identical viral strains.

Keywords: High pathogenicity avian influenza; Human airway epithelium; Influenza A(H5N6); SARS-CoV-2; Viral co-infection; Virus interference; Zoonoses.

 
Back
Top